The antithrombotic-treated patient;Den antitrombotisk behandlede patient

Ugeskrift for Laeger

Volumn 168, Issue 49, 2006, Pages 4296-4299

  Nielsen, Jørn Dalsgaard ^a   Rasmussen, Hans Morten Schnack ^b   Husted, Steen Elkjær ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; DALTEPARIN; DIPYRIDAMOLE; DROTRECOGIN; ENOXAPARIN; FONDAPARINUX; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; PHYTOMENADIONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TINZAPARIN; TIROFIBAN; WARFARIN;

BLEEDING; EMERGENCY CARE; HUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

ANTICOAGULANTS; EMERGENCIES; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEMOSTATICS; HUMANS; INTRAOPERATIVE COMPLICATIONS; PLATELET AGGREGATION INHIBITORS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL PROCEDURES, OPERATIVE; THROMBOEMBOLISM;

EID: 33845384875     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-11.
2. Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy. Clin Pharmacokinet 2004;43:963-81.
3. Dyke CM. Safety of glycoprotein IIb-IIIa inhibitors: a heart surgeon's perspective. Am Heart J 1999;138:S307-S316.
4. Kovacs MJ, Kearon C, Rodger M et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110:1658-63.
5. Torn M, Rosendaal FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003;123:676-82.
6. Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000;38:124-6.
7. Horlocker TT, Wedel DJ, Benzon H et al. Regional anesthesia in the anticoagulated patient: defining the risks. Regional Anesth Pain Med 2004; 29(suppl 1):1-11.
8. Wentzien TH, O'Reilly RA, Kearns PJ. Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged. Chest 1998;114:1546-50.
9. Nielsen JD, Holm-Nielsen A, Jespersen J. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy. Scand J Urol Nephrol 2000;34:194-8.
10. Ernst A, Eberhardt R, Wahidi M. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006;129:734-7.